Your feedback is important to us!
We invite all our readers to share with us their views and comments about this article.
Disclaimer: Comments submitted by third parties on this site are the sole responsibility of the individual(s) whose content is submitted. The Daily Star accepts no responsibility for the content of comment(s), including, without limitation, any error, omission or inaccuracy therein. Please note that your email address will NOT appear on the site.
Alert: If you are facing problems with posting comments, please note that you must verify your email with Disqus prior to posting a comment. follow this link to make sure your account meets the requirements. (http://bit.ly/vDisqus)
European shares held around one-year highs Thursday, supported by mergers and acquisitions-related optimism, with Johnson & Johnson's $30 billion deal to buy Actelion lifting shares in the Swiss biotech firm.Actelion surged 19.4 percent after the U.S. health care giant's move to make an all-cash purchase that includes spinning off Actelion's research and development pipeline. The STOXX 600 added 0.2 percent, building on strong gains seen in the previous session when the pan-European index ended at its highest level since end-December 2015 .
FOLLOW THIS ARTICLE